These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27825696)

  • 1. A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.
    Pin E; Stratton S; Belluco C; Liotta L; Nagle R; Hodge KA; Deng J; Dong T; Baldelli E; Petricoin E; Pierobon M
    Mol Oncol; 2016 Dec; 10(10):1585-1594. PubMed ID: 27825696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
    Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
    BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
    J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.
    Bohonowych JE; Hance MW; Nolan KD; Defee M; Parsons CH; Isaacs JS
    Prostate; 2014 Apr; 74(4):395-407. PubMed ID: 24338924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal pathway profiling of prostate cancer using reverse phase protein arrays.
    Grubb RL; Calvert VS; Wulkuhle JD; Paweletz CP; Linehan WM; Phillips JL; Chuaqui R; Valasco A; Gillespie J; Emmert-Buck M; Liotta LA; Petricoin EF
    Proteomics; 2003 Nov; 3(11):2142-6. PubMed ID: 14595813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Abberant methylation of p16, HIC1, N33 and GSTP1 genes in tumor epitelium and tumor-associated stromal cells of prostate cancer].
    Kekeeva TV; Popova OP; Shegaĭ PV; Alekseev BIa; Adnreeva IuIu; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2007; 41(1):79-85. PubMed ID: 17380894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser Microdissection of Cellular Compartments for Expression Analyses in Cancer Models.
    Han TS; Oshima M
    Methods Mol Biol; 2018; 1725():143-153. PubMed ID: 29322415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.
    Grubb RL; Deng J; Pinto PA; Mohler JL; Chinnaiyan A; Rubin M; Linehan WM; Liotta LA; Petricoin EF; Wulfkuhle JD
    J Proteome Res; 2009 Jun; 8(6):3044-54. PubMed ID: 19275204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance.
    Levesque C; Nelson PS
    Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 28490538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser-capture microdissection in prostate cancer research: establishment and validation of a powerful tool for the assessment of tumour-stroma interactions.
    Shukla CJ; Pennington CJ; Riddick AC; Sethia KK; Ball RY; Edwards DR
    BJU Int; 2008 Mar; 101(6):765-74. PubMed ID: 18190638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asporin is a stromally expressed marker associated with prostate cancer progression.
    Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
    Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reactive stroma microenvironment and prostate cancer progression.
    Barron DA; Rowley DR
    Endocr Relat Cancer; 2012 Dec; 19(6):R187-204. PubMed ID: 22930558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment.
    Fitzgerald S; Espina V; Liotta L; Sheehan KM; O'Grady A; Cummins R; O'Kennedy R; Kay EW; Kijanka GS
    J Transl Med; 2018 Apr; 16(1):89. PubMed ID: 29631612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.
    Kumar B; Rosenberg AZ; Choi SM; Fox-Talbot K; De Marzo AM; Nonn L; Brennen WN; Marchionni L; Halushka MK; Lupold SE
    Sci Rep; 2018 May; 8(1):7189. PubMed ID: 29739972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A.
    Bhattacharyya S; Feferman L; Tobacman JK
    Prostate; 2019 May; 79(7):689-700. PubMed ID: 30801800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer.
    Tyekucheva S; Bowden M; Bango C; Giunchi F; Huang Y; Zhou C; Bondi A; Lis R; Van Hemelrijck M; Andrén O; Andersson SO; Watson RW; Pennington S; Finn SP; Martin NE; Stampfer MJ; Parmigiani G; Penney KL; Fiorentino M; Mucci LA; Loda M
    Nat Commun; 2017 Sep; 8(1):420. PubMed ID: 28871082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser Capture Microdissection as a Tool to Study Tumor Stroma.
    Bertos NR; Park M
    Methods Mol Biol; 2016; 1458():13-25. PubMed ID: 27581011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.
    Hägglöf C; Hammarsten P; Josefsson A; Stattin P; Paulsson J; Bergh A; Ostman A
    PLoS One; 2010 May; 5(5):e10747. PubMed ID: 20505768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.